Learn how to interpret your PSMA-PET scan results, understand SUV metrics, and track metastatic prostate cancer treatment options and progress.

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

Answer: The most common diagnostic tool for prostate cancer is a blood test for a prostate-specific antigen (PSA). PSA is a ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Mical Roy is an Austin-based senior manager in public affairs, a prostate cancer survivor, and a content writer. He's also the co-founder of the Pink and Blue Affair, an annual event in Bastrop County ...